Greenwich LifeSciences(GLSI)
$18.70+4.94 (+35.90%)
GLSI
Greenwich LifeSciences financials statements
$18.70
At close:+4.94 (+35.90%)
Greenwich LifeSciences (GLSI) Ratios
451 Followers
Greenwich LifeSciences Ratios
GLSI's free cash flow for Q2 2026 was $-1.94M. For the 2026 fiscal year, GLSI's free cash flow was increased by $0.00 and operating cash flow was $-1.94M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.06 | 2.62 | 23.74 | 51.23 | 70.63 |
| Quick Ratio | 1.06 | 2.62 | 23.74 | 51.23 | 70.63 |
| Cash Ratio | 1.06 | 2.62 | 23.74 | 51.23 | 70.63 |
| Solvency Ratio | -3.32 | -11.16 | -30.19 | -29.75 | -11.86 |
| Operating Cash Flow Ratio | -1.70 | -4.66 | -22.01 | -23.58 | -11.14 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 353.22K | $ 2.53M | $ 6.70M | $ 13.21M | $ 26.82M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 17.49 | 1.62 | 1.04 | 1.02 | 1.01 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.32 | 0.24 | 0.75 | 1.68 | 5.92 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 99.54% | 98.74% | 95.33% | 97.33% | 99.40% |
| Return on Assets (ROA) | -313.34% | -425.38% | -127.12% | -58.06% | -16.79% |
| Return on Equity (ROE) | -5480.55% | -687.21% | -132.71% | -59.22% | -17.03% |
| Return on Capital Employed (ROCE) | -5505.94% | -696.01% | -139.21% | -60.85% | -17.14% |
| Return on Invested Capital (ROIC) | -5505.94% | -696.01% | -139.21% | -60.85% | -17.14% |
| Return on Tangible Assets | -313.34% | -425.57% | -127.22% | -58.10% | -16.80% |
| Earnings Yield | -6.81% | -11.91% | -6.58% | -3.99% | -1.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1000105.95 | -118992.43 | -3584.52 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1000105.95 | 118992.43 | 3584.52 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.73 | -0.56 | -0.50 | -0.48 | -0.33 |
| Free Cash Flow Per Share | -0.73 | -0.56 | -0.50 | -0.48 | -0.33 |
| Dividend Paid and CapEx Coverage Ratio | -3304484.33 | -2422181.00 | 0.00 | -2066675.67 | 0.00 |
| Capital Expenditure Coverage Ratio | -3304484.33 | -2422181.00 | 0.00 | -2066675.67 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -3.49% | -4.97% | -4.79% | -3.16% | -1.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.69 | -9.28 | -15.20 | -25.08 | -68.90 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 805.09 | 57.68 | 20.17 | 14.85 | 11.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -28.69 | -20.11 | -20.86 | -31.66 | -73.38 |
| Price-to-Operating Cash Flow Ratio | -28.69 | -20.11 | -20.86 | -31.66 | -73.38 |
| Price-to-Earnings Growth (PEG) Ratio | -0.81 | -0.12 | -1.16 | -0.34 | -0.52 |
| Enterprise Value Multiple | -14.37 | -8.16 | -13.75 | -22.75 | -62.63 |
| Enterprise Value | 278.19M | 142.06M | 128.17M | 182.82M | 287.73M |
| EV to EBITDA | -14.37 | -8.16 | -13.75 | -22.75 | -62.63 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -28.06 | -19.55 | -19.78 | -29.49 | -67.04 |
| EV to Operating Cash Flow | -28.06 | -19.55 | -19.78 | -29.49 | -67.04 |
| Tangible Book Value Per Share | 0.03 | 0.19 | 0.52 | 1.02 | 2.07 |
| Shareholders’ Equity Per Share | 0.03 | 0.19 | 0.52 | 1.02 | 2.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.43 | -1.34 | -0.69 | -0.61 | -0.35 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.95 | 0.97 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.51 | 0.46 | 0.73 | 0.79 | 0.94 |
Currency in USD

